Fresenius Medical Care reserves €200 million in FCPA case

Germany-based Fresenius Medical Care, a provider of dialysis products and services, has set aside €200 million concerning its ongoing settlement negotiations with the U.S. government regarding potential violations of the Foreign Corrupt Practices Act.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.